Piki Picchi's Contract to 2028: When Como Women Chose What the Stats Sheet Cannot Measure

Three in the morning in Chengdu, my phone buzzed. A colleague in Milan sent exactly one line: "Como just extended the contract of a player being treated for breast cancer." I sat up, opened my laptop, and read the official statement from the women's football club Como Women about forward Roberta "Piki" Picchi.

No scoreline. No clinical detail. No return date. Only three facts on the table: a breast cancer diagnosis, a contract extended to June 2028, and a commitment to support her medically and personally.

2 a.m., the phone rings, and a truth cracks open. This time the truth is not in any number. It is in the blank space — where a stats table should be, and there is nothing.

People call me a heretic, but I only see what they refuse to look at. In a transfer story, that blank space signals a deal not yet done. In a welfare story, that blank space signals a boundary being respected. The two look identical on a screen, but they are read completely differently.

In men's football, a case like this usually comes with three things: a controlled medical statement, clear insurance clauses, and a recovery timeline agreed by club and agent. In women's football, the safety net is far thinner. Contracts are shorter, wages are lower, and not every player has protective clauses when a career is interrupted by illness.

That is why an extension to June 2028 is the most important fact in the entire announcement — more important than the club's name, more important than the forward position, more important than any praise on social media.

Extending the contract of a player with no known return date is a structural decision, not a sporting one. It moves financial risk from individual shoulders to institutional ones. Once the paperwork runs to 2028, the question is no longer whether she can play, but if she cannot, who pays, and until when.

On the sporting side, the impact is nearly impossible to measure. The statement provides no performance data, no squad role, no replacement plan. A forward can be the final link in an attacking system, or merely a rotation option. Women's football has very little public data at that level of detail, so any purely technical analysis here is built on sand.

Based on my experience watching matches in European women's leagues, average contract length for mid-tier players is usually one to two seasons, and most are renewed year by year on form. A deal that outlasts the normal transfer cycle, given to someone with no known return date, sits outside standard operating logic. It cannot be explained by football reasons.

Operationally, this is a controlled gamble. If the player returns, the club gains an attacking option at zero transfer cost. If she never returns to her peak, the wages and support obligations still sit inside an approved budget — provided insurance or medical clauses are attached. Those details have not been published, and rightly so. We have no right to demand them.

On reputation, the club gains the hardest thing to buy in European women's football: legitimacy. Women's leagues are struggling with audiences, with broadcast rights, with sponsor trust. An act perceived as decent carries far more media value than a cup-qualifier win.

I remember a 2 a.m. call during the pandemic. A reserve goalkeeper in China, nicknamed "Fat Cat," told me about his fear of being forgotten while the stands sat empty. What scared him was not injury. It was the silence afterwards. Professional football is designed to keep running without anyone — and that is exactly where a contract to 2028 matters.

I will sail against the wind a little, because that is what I do. A decent act published publicly is also a media asset. That does not make it fake. But if we stop at praise, we skip the hardest part: most women footballers in Europe and Asia do not have a club willing to sign them until 2028. They have one-year deals, unfinished degrees, hospital bills, and nobody covering them.

The blind spot here sits in the insurance system, not in the tactical shape. If Como Women announced an extension without a medical protection structure, that is generosity funded by the player herself in later years. If that structure exists, this is a new standard the rest of women's football should be forced to follow.

And one more thing: do not guess the return date. I once paid a price for mispronouncing a player's name on live broadcast. That night I stammered, but history did not. I had to rewatch tape for thirty days before I dared write a sentence. With a medical case, the cost of guessing is not a mocking comment. It is a human being.

What I will be watching over the next eighteen months: whether Picchi returns and the club publishes a pathway; whether other women's clubs turn contract extensions for players in treatment into a minimum standard; and whether a story like this, ten years from now, is still rare enough to be news.

Women's football is growing through contracts like this one, not through 90th-minute goals. When a club pays the wages of someone who cannot take the pitch, what it is buying is not a forward. It is the right to exist without having to prove you are useful.